Protective Effect of Lactation Against Gestational Diabetes Mellitus in Subsequent Pregnancies: A Prospective Observational Cohort Study

Recruiting now

Conditions studied: Gestational Diabetes Mellitus (GDM), Lactating Mother

In brief

Gestational diabetes mellitus (GDM) is a common metabolic disorder of pregnancy associated with increased maternal and fetal morbidity. Lactation has been suggested to improve maternal glucose metabolism, enhance insulin sensitivity, and reduce the risk of future glucose intolerance. However, evidence regarding the protective effect of lactation on the development of GDM in subsequent pregnancies remains limited. This prospective observational cohort study aims to evaluate the association between lactation and the risk of gestational diabetes mellitus and related pregnancy complications in women who conceive during the lactation period. Routine glycemic markers including fasting plasma glucose, HbA1c, glycosuria, and 75-g oral glucose tolerance test (OGTT) results will be recorded. Ultrasonographic findings including fetal abdominal circumference percentile, estimated fetal weight percentile, and amniotic fluid index will also be assessed. The study will investigate whether lactation is associated with a reduced risk of GDM, fetal macrosomia, and polyhydramnios in subsequent pregnancies.

Key facts

Study ID

NCT07624968

Run by

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

People needed

140

Starts

2026-01-15

Expected to finish

2027-12-31

Last updated by the study team

2026-06-03

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Pregnant individuals aged 18 to 50 years.
• Singleton pregnancy.
• Conception during the lactation period.
• Follow-up at Prof. Dr. Cemil Taşcıoğlu City Hospital or Esenyurt Necmi Kadıoğlu State Hospital.
• Availability of glycemic parameters including fasting plasma glucose, HbA1c, glycosuria, and 75-g oral glucose tolerance test (OGTT) results.
• Availability of routine ultrasonographic measurements including fetal abdominal circumference percentile (AC), estimated fetal weight percentile (EFW), and amniotic fluid index (AFI).

You may not qualify if…

• Age below 18 years.
• Age above 50 years.
• Multiple pregnancy.
• Known chronic systemic disease or pre-existing diabetes mellitus.
• Missing clinical, laboratory, or ultrasonographic data.

Where it is running

• Prof. Dr. Cemil Taşcıoğlu City Hospital — Istanbul, Turkey (Türkiye) (enrolling)
• Esenyurt Necmi Kadıoğlu State Hospital — Istanbul, Turkey (Türkiye) (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.